MDMA-assisted therapy and current treatment options for chronic, treatment-resistant, moderate or higher severity post-traumatic stress disorder: Systematic literature review.
PLoS One 2025 Filip Stanicic, Vladimir Zah, Dimitrije Grbic et al. 5 citations
3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) is currently being evaluated for treatment of patients with moderate or higher severity post-traumatic stress disorder (PTSD). To provide a comprehensive summary of investigational MDMA-AT and current treatments for PTSD. A search was conducted in PubMed and Embase (December 20, 2023). Populations included adults with chronic,...
DOI: 10.1371/journal.pone.0327778 (opens in new tab)
Full text (opens in new tab)
Psychedelic therapy
MDMA-Assisted Therapy
MDMA-At
MDMA Therapy
+12